Protox Announces Positive Phase 2 BPH Results
(EMAILWIRE.COM, November 25, 2008 ) Vancouver, British Columbia - Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced positive data from its Phase 2 study of PRX302 in patients with benign prostatic hyperplasia (BPH), a painful...more
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International
Equityallianceir.com
Your text Ads & PR
Text Ads plus unlimited press releases, One release featured/Day for only $575 per month.
Read more on Text Ads & PR
Your text Ads Here!
Text Ads are only $289 per month. Ads are placed same day.
More on Text Ads Advertising
Press Release
Resources
Benefits of Online Press Release Distribution Service
Press Releases
Press Release Examples
Press Release Format
Press Release Free
Press Release Service Comparison
Press Release Writing
Press release Writing Tips